Evidence map›Paper›PMID 34264971›Full record

ArticlePloS one2021

Prevalence of male circumcision in four culturally non-circumcising counties in western Kenya after 10 years of program implementation from 2008 to 2019.

Elijah Odoyo-June, Stephanie Davis, Nandi Owuor, Catey Laube, Jonesmus Wambua, Paul Musingila, Peter W Young, Appolonia Aoko, Kawango Agot, Rachael Joseph and 5 more

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Elijah Odoyo-JuneU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB, Nairobi, Kenya.ORCID 0000-0002-1370-2306
Stephanie DavisU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB Atlanta, GA, United States of America.
Nandi OwuorJhpiego, Nairobi, Kenya.
Catey LaubeJhpiego, Baltimore, Maryland, United States of America.
Jonesmus WambuaJhpiego, Nairobi, Kenya.
Paul MusingilaU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB, Nairobi, Kenya.
Peter W YoungU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB, Nairobi, Kenya.ORCID 0000-0002-7432-2876
Appolonia AokoU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB, Nairobi, Kenya.
Kawango AgotImpact Research and Development Organization (IRDO), Kisumu, Kenya.
Rachael JosephU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB, Nairobi, Kenya.
Zebedee MwandiJhpiego, Nairobi, Kenya.
Vincent OjiamboUSAID, Nairobi, Kenya.
Todd LucasU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB Atlanta, GA, United States of America.ORCID 0000-0002-8785-1830
Carlos ToledoU.S. Centers for Disease Control and Prevention (CDC), Division of HIV & TB Atlanta, GA, United States of America.
Ambrose WanyonyiNational AIDS and STI Control Program (NASCOP), Ministry of Health, Nairobi, Kenya.

Funding

CDC HHSPEPFAR
6 · The paper itself

Abstract

introductionKenya started implementing voluntary medical male circumcision (VMMC) for HIV prevention in 2008 and adopted the use of decision makers program planning tool version 2 (DMPPT2) in 2016, to model the impact of circumcisions performed annually on the population prevalence of male circumcision (MC) in the subsequent years. Results of initial DMPPT2 modeling included implausible MC prevalence estimates, of up to 100%, for age bands whose sustained high uptake of VMMC pointed to unmet needs. Therefore, we conducted a cross-sectional survey among adolescents and men aged 10-29 years to determine the population level MC prevalence, guide target setting for achieving the goal of 80% MC prevalence and for validating DMPPT2 modelled estimates.

methodsBeginning July to September 2019, a total of 3,569 adolescents and men aged 10-29 years from households in Siaya, Kisumu, Homa Bay and Migori Counties were interviewed and examined to establish the proportion already circumcised medically or non-medically. We measured agreement between self-reported and physically verified circumcision status and computed circumcision prevalence by age band and County. All statistical were test done at 5% level of significance.

resultsThe observed MC prevalence for 15-29-year-old men was above 75% in all four counties; Homa Bay 75.6% (95% CI [69.0-81.2]), Kisumu 77.9% (95% CI [73.1-82.1]), Siaya 80.3% (95% CI [73.7-85.5]), and Migori 85.3% (95% CI [75.3-91.7]) but were 0.9-12.4% lower than DMPPT2-modelled estimates. For young adolescents 10-14 years, the observed prevalence ranged from 55.3% (95% CI [40.2-69.5]) in Migori to 74.9% (95% CI [68.8-80.2]) in Siaya and were 25.1-32.9% lower than DMMPT 2 estimates. Nearly all respondents (95.5%) consented to physical verification of their circumcision status with an agreement rate of 99.2% between self-reported and physically verified MC status (kappa agreement p-value<0.0001).

conclusionThis survey revealed overestimation of MC prevalence from DMPPT2-model compared to the observed population MC prevalence and provided new reference data for setting realistic program targets and re-calibrating inputs into DMPPT2. Periodic population-based MC prevalence surveys, especially for established programs, can help reconcile inconsistencies between VMMC program uptake data and modeled MC prevalence estimates which are based on the number of procedures reported in the program annually.

Indexed as

Circumcision, MaleAdolescentAdultChildCross-Sectional StudiesHIV InfectionsHumansKenyaMalePrevalenceYoung Adult

Identifiers

PMID34264971
PMCPMC8281999

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.